BresoDx is launching this Saturday at ERS in London and we are there to support them. We are pleased to announce that we are now the exclusive distributors of the BresoDx diagnostic device in the UK and Republic of Ireland.
BresoDx has been approved in Europe as an aid in the diagnosis of sleep apnoea. The innovative device uses proprietary acoustic and movement recording technology to detect apnoea events. It is a cordless, battery operated device that provides results with a 94-96% correlation to the current gold standard of PSG. It has the versatility to be used for independent patient use in the comfort of their own home, or with minimal assistance in a hospital ward or sleep clinic. BresoDx has been tested and validated for its accuracy in several clinical trials led by Drs. Hisham Alshaer and Douglas Bradley of the University Health Network. It is a reliable and cost effective solution that can enhance the field of sleep apnoea diagnosis for physicians, patients and health care providers.
To find out more about the BresoDx Sleep Apnoea Diagnostic device, click here.
BresoDx has been approved in Europe as an aid in the diagnosis of sleep apnoea. The innovative device uses proprietary acoustic and movement recording technology to detect apnoea events. It is a cordless, battery operated device that provides results with a 94-96% correlation to the current gold standard of PSG. It has the versatility to be used for independent patient use in the comfort of their own home, or with minimal assistance in a hospital ward or sleep clinic. BresoDx has been tested and validated for its accuracy in several clinical trials led by Drs. Hisham Alshaer and Douglas Bradley of the University Health Network. It is a reliable and cost effective solution that can enhance the field of sleep apnoea diagnosis for physicians, patients and health care providers.
To find out more about the BresoDx Sleep Apnoea Diagnostic device, click here.
RSS Feed